Skip to main content
Displaying 25 - 36 of 40
Display:
12
24
48
General Hepatology
4
Gore & Associates: Small TIPS for the right reason, right patient at the right time - ILC 2022
View
Cirrhosis & Complications
1
Sobi: When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD) - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unmasking NASH: the hepatic face of metabolic dysregulation - ILC 2021
View
General Hepatology
4
Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021
View
General Hepatology
4
Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021
View
General Hepatology
4
Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021
View
General Hepatology
4
Gore & Associates: New clinical evidence demonstrates improved survival when selecting smaller TIPS and earlier TIPS - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: NASH – the metabolic disease of the liver - Digital ILC 2020
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy